🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07586605
Starting soon Not applicable

Lying Positions in Intramuscular Injection

NCT07586605 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-30
Last updated
2026-05-22

Condition(s) studied

Ventrogluteal Injections

Investigational drug(s) / intervention(s)

Lying before procedure

Lying before procedure: Lying position before intramuscular injection

Study summary

The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being 18 years of age or older, * Having received an IM injection at least one week prior to the study, * Absence of scars, ecchymosis, or hematomas at the injection site, * Having a BMI between 18.5 and 24.9 kg/m², * Absence of lower extremity paralysis, * Not receiving any oral or parenteral analgesic treatment prior to the injection. Exclusion Criteria: * Failure of the patient to respond to the questions in the post-procedure data collection form.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yalova University Yalova Turkey (Türkiye)

More University of Yalova trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07586605 on ClinicalTrials.gov ↗ ← All trials in Turkey